SightfileU.S. market data from official filings

ENVISTA HOLDINGS CORPORATION (NVST)

Name: ENVISTA HOLDINGS CORPORATION (NVST) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001757073 · EDGAR filings · Updated 2026-06-03

ENVISTA HOLDINGS CORPORATION (NVST) has reported institutional ownership of 109.5%, with 386 institutional managers holding positions valued at $4.50B per the latest 13F reporting period.

Institutional ownership

109.5%

Institutional managers

386

Reported 13F value

$4.50B

Insider activity

35 trans.

−$614.2K net selling

Latest updates

2026-06-03 — Current report (8-K) filed
2026-05-28 — SD filed
2026-05-27 — Insider transaction reported (Form 4)
2026-05-21 — Insider transaction reported (Form 4)
2026-05-21 — Insider transaction reported (Form 4)
2026-05-21 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ENVISTA HOLDINGS CORPORATION has 386 institutional holders and institutional ownership of 109.5%.

Insider activity

Insiders reported 35 transactions (0 buys, 3 sells) across 16 reporting insiders, with a net reported value of −$614.2K.

Related companies

QIAGEN NV (QGEN) · CHEMED CORP NEW (CHE) · BRUKER CORP COM (BRKR) · CRINETICS PHARMACEUTICALS IN (CRNX) · OPTION CARE HEALTH INC (OPCH) · ERASCA INC (ERAS)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-03.